Company profile: Paragon Bioservices
1.1 - Company Overview
Company description
- Provider of contract development and manufacturing services for complex biopharmaceuticals, including AAV, oncolytic viruses, and next-generation vaccines. An industry-leading, private-equity backed CDMO focused on developing and manufacturing cutting-edge, transformative biopharmaceuticals and building strong client partnerships with the world's best biotech and pharma companies.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Paragon Bioservices
ScanModul
HQ: Germany
Website
- Description: Provider of engineered healthcare storage equipment and services throughout Europe, offering ISO-certified modular tray and basket systems, mobile ScanCell storage solutions, SmartCabinet RFID systems for real-time management of medical devices and implants, and NoCount software supporting hospital supply-chain planning and delivery based on actual needs, enabling automatic data capture to increase efficiency and safety.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ScanModul company profile →
Cellumen
HQ: United States
Website
- Description: Provider of cellular systems biology solutions delivering accurate predictions of drug efficacy and safety to drive Discovery Toxicology and reduce failure rates and development costs. Offers biomarker analysis tools, including for COVID-19 and cardiac issues, cloning, assay kits (ELISA and protein), and cDNA for research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cellumen company profile →
Fusion Antibodies
HQ: United Kingdom
Website
- Description: Provider of humanized monoclonal antibody production and antibody engineering services, including mammalian display for high-volume screening, antibody humanization (CDRx), affinity maturation (RAMP), OptiMAL mammalian antibody library for discovery and preclinical optimization, integrated antibody discovery strategies, and protein engineering.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fusion Antibodies company profile →
Pharm-Olam
HQ: United States
Website
- Description: Provider of comprehensive clinical research services as a multi-national contract research organization serving pharmaceutical, biotechnology, and medical device industries, with a global network including Central Eastern Europe, Latin America, and India to enable patient recruitment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pharm-Olam company profile →
Inke
HQ: Spain
Website
- Description: Provider of high-quality active pharmaceutical ingredients (APIs) with sophisticated synthesis procedures, primarily for respiratory and central nervous system (CNS) therapies, including specialized inhalation APIs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inke company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Paragon Bioservices
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Paragon Bioservices
2.2 - Growth funds investing in similar companies to Paragon Bioservices
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Paragon Bioservices
4.2 - Public trading comparable groups for Paragon Bioservices
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →